Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XRNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.350.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.254NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.39.1.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.418NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.9.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.40NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.122NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAJNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.431NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.168NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.6 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.97NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.32NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.67NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBSNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.2.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAHNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBJ.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EP.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CL.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.8.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAUNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAY.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.25.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XADNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XABNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FT.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XALNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBWNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAY.1.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GY.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBF.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GA.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAY.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.38NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CT.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.10.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FF.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.60NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.11NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used